Precision Nursing vs Conventional Care in Laparoscopic Colorectal Cancer Surgery: A Randomized Controlled Trial

May 26, 2026 updated by: Mei Fang, Jiangsu Cancer Institute & Hospital

Comparison of Perioperative Outcomes Between Precision Nursing and Conventional Care in Laparoscopic Colorectal Cancer Surgery: a Randomized Controlled Trial

This single-center randomized controlled trial compares the effects of precision nursing and conventional care in patients undergoing laparoscopic colorectal cancer surgery.

Precision nursing includes personalized preoperative psychological counseling, intraoperative body temperature and position management, and postoperative targeted recovery guidance. Conventional care follows routine clinical nursing procedures.

The study will assess differences in perioperative outcomes (such as anxiety, intraoperative hypothermia, postoperative nausea and vomiting, recovery time, and hospital stay) between the two groups, to provide evidence for optimizing nursing strategies for colorectal cancer surgery patients.

Study Overview

Detailed Description

Study Background: Laparoscopic colorectal cancer surgery is a common treatment, but perioperative complications (e.g., hypothermia, nausea) and anxiety affect patient recovery. Precision nursing may improve these outcomes, but evidence from RCTs is limited.

Study Design: A parallel-group randomized controlled trial. 90 eligible patients are randomly assigned (1:1) to the precision nursing group or conventional care group.

Interventions:

Precision Nursing Group:

  1. Preoperative: 30-minute personalized psychological counseling + music therapy;
  2. Intraoperative: Real-time body temperature monitoring (maintaining ≥36°C) + dynamic position optimization;
  3. Postoperative: Individualized recovery guidance (early ambulation, dietary adjustment) based on patient condition.

Conventional Care Group: Routine clinical nursing (preoperative health education, intraoperative basic monitoring, postoperative standard care).

Outcome Measures:

Primary: Preoperative anxiety score (SAQ), intraoperative hypothermia rate, postoperative nausea and vomiting (PONV) incidence, time to first flatus, length of hospital stay; Secondary: Postoperative complication rate, nursing satisfaction score.

Statistical Analysis: Data are analyzed using SPSS 26.0. Continuous variables are compared with t-tests, categorical variables with chi-square tests. A p-value <0.05 is considered statistically significant.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Jiangsu
      • Nanjing, Jiangsu, China, 210009
        • Jiangsu Cancer Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients diagnosed with colorectal cancer and scheduled for laparoscopic surgery.
  • Age 18 to 80 years old.
  • Able to understand and complete the study questionnaires.
  • Voluntarily agree to participate in this study and sign the informed consent form.

Exclusion Criteria:

  • Severe cognitive impairment or mental illness.
  • Emergency surgery patients.
  • Severe cardiopulmonary, hepatic, or renal dysfunction.
  • Patients who cannot cooperate with perioperative nursing interventions.
  • Participation in other clinical trials that may affect this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Precision Nursing Group
Participants in this arm receive personalized perioperative care, including 30-minute preoperative psychological counseling, real-time intraoperative body temperature monitoring (maintaining ≥36°C), and postoperative individualized recovery guidance (early ambulation, dietary adjustment).
Personalized perioperative care including 30-minute preoperative psychological counseling, real-time intraoperative body temperature monitoring (maintaining ≥36°C), and postoperative individualized recovery guidance (early ambulation, dietary adjustment).
Active Comparator: Conventional Care Group
Participants in this arm receive routine perioperative clinical nursing, including standard preoperative health education, basic intraoperative monitoring, and postoperative standard care without personalized interventions.
Routine perioperative clinical nursing, including standard preoperative education, basic monitoring, and standard postoperative care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preoperative anxiety score
Time Frame: 1 day before surgery
Anxiety level of participants is evaluated using a validated Self-Rating Anxiety Scale (SAS). The scale consists of 20 items, with total scores ranging from 20 to 80 points. A higher score indicates a more severe level of preoperative anxiety.
1 day before surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2026

Primary Completion (Actual)

May 1, 2026

Study Completion (Actual)

May 1, 2026

Study Registration Dates

First Submitted

February 10, 2026

First Submitted That Met QC Criteria

February 10, 2026

First Posted (Actual)

February 17, 2026

Study Record Updates

Last Update Posted (Actual)

May 29, 2026

Last Update Submitted That Met QC Criteria

May 26, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colorectal Cancer

  • University of California, San Francisco
    Completed
    Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditions
    United States
  • University of Southern California
    National Cancer Institute (NCI)
    Active, not recruiting
    Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditions
    United States
  • Fred Hutchinson Cancer Center
    National Cancer Institute (NCI)
    Terminated
    Rectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditions
    United States
  • M.D. Anderson Cancer Center
    Recruiting
    Colorectal Adenocarcinoma | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage... and other conditions
    United States
  • Sidney Kimmel Comprehensive Cancer Center at Thomas...
    United States Department of Defense
    Active, not recruiting
    Colorectal Adenoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage 0 Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal... and other conditions
    United States
  • M.D. Anderson Cancer Center
    National Cancer Institute (NCI)
    Active, not recruiting
    Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditions
    United States
  • Wake Forest University Health Sciences
    National Cancer Institute (NCI)
    Completed
    Cancer Survivor | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal Cancer AJCC v8 | Stage IIB Colorectal... and other conditions
    United States
  • Emory University
    Bristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...
    Completed
    Colorectal Cancer Metastatic | Colorectal Adenocarcinoma | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Refractory Colorectal Carcinoma | Metastatic Microsatellite Stable Colorectal Carcinoma | Stage IVC Colorectal Cancer
    United States
  • University of Roma La Sapienza
    Completed
    Colorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Cancer Stage 0 | Colorectal Cancer Stage I
    Italy
  • University of Southern California
    National Cancer Institute (NCI); Amgen
    Terminated
    Stage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Colorectal Adenocarcinoma | RAS Wild Type | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer...
    United States

Clinical Trials on Precision Nursing

Subscribe